Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
EBITDA for Q1 FY25 is at Rs. 100 crore compared to Rs. 32 crore in the previous year
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Bluecrux's digital supply chain twin technology, Axon, plays a critical role in Sanofi's digital supply chain transformation.
The award recognizes powerful science–industry collaborations for social good
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Subscribe To Our Newsletter & Stay Updated
